Condition
Prognostic Stage IIB Breast Cancer AJCC v8
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 65 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownPersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerNCT06324240 · 2025-12-02
RECRUITINGTopical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast CancerNCT05417308 · 2023-03-01
RECRUITINGDecision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerNCT02918474 · 2017-04-28
RECRUITINGSTEMVAC in Patients With Early Stage Triple Negative Breast CancerNCT05455658 · 2022-11-17
ACTIVE_NOT_RECRUITINGHealth Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer SurvivorsNCT05674578 · 2022-11-14
COMPLETEDTranscutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast CancerNCT05368428 · 2022-10-19
TERMINATEDPrecision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyNCT04835597 · 2022-08-15
TERMINATEDDiabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer SurvivorsNCT04560439 · 2022-06-15
WITHDRAWNPiloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer SurvivorsNCT05452681 · 2022-06-01
TERMINATEDA Quality of Life Intervention for Young African American Breast Cancer Survivors in TreatmentNCT05243056 · 2022-06-01
TERMINATEDRibociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerNCT05319873 · 2022-04-07
ACTIVE_NOT_RECRUITINGStandard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyNCT04993313 · 2022-03-18
ACTIVE_NOT_RECRUITINGSocial Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsNCT07259304 · 2021-11-24
ACTIVE_NOT_RECRUITINGAn Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsNCT05012176 · 2021-11-01
COMPLETEDMobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast CancerNCT05086731 · 2021-10-22
COMPLETEDSafely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelNCT04862585 · 2021-10-07
COMPLETEDOxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsNCT04290897 · 2021-09-29
COMPLETEDCulturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyNCT04754412 · 2021-07-23
ACTIVE_NOT_RECRUITINGWeb-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer SurvivorsNCT04906200 · 2021-06-28
ACTIVE_NOT_RECRUITINGAbemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast CancerNCT04481113 · 2021-06-07
COMPLETEDRadiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast CancerNCT04871516 · 2021-05-18
ACTIVE_NOT_RECRUITINGTreatment Decision Making in African American Women Diagnosed With Triple Negative Breast CancerNCT05071677 · 2021-05-03
COMPLETEDCognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025 · 2021-04-08
TERMINATEDMultiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer SurvivorsNCT04999826 · 2021-04-01
COMPLETEDImproving Patient-Centered Communication in Breast Cancer Through Patient and Provider InterventionsNCT04549571 · 2021-02-16
ACTIVE_NOT_RECRUITINGHealth Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyNCT04927559 · 2020-12-18
TERMINATEDNilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast CancerNCT04205903 · 2020-12-11
COMPLETEDNipple Aspirate Fluid in Detecting Breast CancerNCT03715959 · 2020-12-10
COMPLETEDExercise During Chemotherapy in Older Women With Stage I-III Breast CancerNCT05025059 · 2020-12-03
ACTIVE_NOT_RECRUITINGProspective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)NCT04537312 · 2020-11-17
ACTIVE_NOT_RECRUITINGLorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerNCT04205071 · 2020-11-01
WITHDRAWNPlatelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast CancerNCT04535323 · 2020-09-23
COMPLETEDRifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast CancerNCT04249622 · 2020-09-18
TERMINATEDRBX7455 Before Surgery for the Treatment of Operable Breast CancerNCT04139993 · 2020-08-31
TERMINATEDNab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN AlterationsNCT04216472 · 2020-07-10
TERMINATEDImpact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and HandNCT04876378 · 2020-05-18
TERMINATEDAnastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerNCT04294225 · 2020-04-28
COMPLETEDCompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyNCT04266249 · 2020-03-13
ACTIVE_NOT_RECRUITINGTai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialNCT04716920 · 2020-03-11
COMPLETEDLifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsNCT04200482 · 2020-02-21
COMPLETEDAbemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerNCT03979508 · 2020-01-10
TERMINATEDChemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerNCT04081389 · 2019-12-06
COMPLETEDDietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase InhibitorsNCT03953157 · 2019-10-07
COMPLETEDAtorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyNCT03872388 · 2019-09-23
TERMINATEDDocetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerNCT04001829 · 2019-08-09
ACTIVE_NOT_RECRUITINGIpilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedNCT04185311 · 2019-07-10
TERMINATEDTreatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481 · 2019-05-14
ACTIVE_NOT_RECRUITINGInfertility Survey Among Reproductive Age Women With Gynecological and Breast CancerNCT04678414 · 2019-04-01
ACTIVE_NOT_RECRUITINGExercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer SurvivorsNCT03751449 · 2019-03-25
TERMINATEDExercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer SurvivorsNCT04454086 · 2019-03-06
COMPLETEDIntensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast CancerNCT03786354 · 2019-01-09
ACTIVE_NOT_RECRUITINGA Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerNCT04086875 · 2018-11-07
UNKNOWNCarbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyNCT03666819 · 2018-09-10
WITHDRAWNHydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast CancerNCT03774472 · 2018-08-20
COMPLETEDM7824 in Treating Patients With Stage II-III HER2 Positive Breast CancerNCT03620201 · 2018-08-03
COMPLETEDAcupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast CancerNCT03505671 · 2018-08-03
COMPLETEDStress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast CancerNCT03505736 · 2018-06-21
COMPLETEDMolecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast CancerNCT03518242 · 2018-06-06
COMPLETEDExercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsNCT03523195 · 2018-04-18
COMPLETEDDurvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast CancerNCT03132467 · 2017-06-13
COMPLETEDCommon interventions
Questionnaire AdministrationOTHER30Quality-of-Life AssessmentOTHER23Best PracticeOTHER9Survey AdministrationOTHER8PaclitaxelDRUG5Educational InterventionOTHER4Exercise InterventionBEHAVIORAL4InterviewOTHER4Biospecimen CollectionPROCEDURE3DocetaxelDRUG3Informational InterventionOTHER3Medical Device Usage and EvaluationOTHER3AbemaciclibDRUG2CapecitabineDRUG2CyclophosphamideDRUG2Dietary InterventionDIETARY_SUPPLEMENT2DiscussionPROCEDURE2IpilimumabBIOLOGICAL2LetrozoleDRUG2Magnetic Resonance ImagingPROCEDURE2Nab-paclitaxelDRUG2PertuzumabBIOLOGICAL2Therapeutic Conventional SurgeryPROCEDURE2TrastuzumabBIOLOGICAL23-Dimensional Conformal Radiation TherapyRADIATION1
Leading sponsors
M.D. Anderson Cancer Center
15
Ohio State University Comprehensive Cancer Center
11
Mayo Clinic
7
Jonsson Comprehensive Cancer Center
5
Emory University
3
Fred Hutchinson Cancer Center
3
ECOG-ACRIN Cancer Research Group
2
OHSU Knight Cancer Institute
2
Roswell Park Cancer Institute
2
Thomas Jefferson University
2
University of Alabama at Birmingham
2
University of Southern California
2
Wake Forest University Health Sciences
2
Alliance for Clinical Trials in Oncology
1
City of Hope Medical Center
1
Trial status mix
COMPLETED27
ACTIVE_NOT_RECRUITING17
TERMINATED14
RECRUITING3
WITHDRAWN3
UNKNOWN1
Phase mix
NA28
PHASE216
PHASE112
EARLY_PHASE12
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.